Literature DB >> 17786073

Management of hypertension complicated by psychiatric comorbidity.

Murray Esler1, Rosemary Schwarz.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17786073      PMCID： PMC8110168          DOI： 10.1111/j.1524-6175.2007.06540.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  20 in total

Review 1.  Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment.

Authors:  S J Mann
Journal:  Arch Intern Med       Date:  1999-04-12

Review 2.  Mechanisms of sympathetic activation in obesity-related hypertension.

Authors:  Murray Esler; Nora Straznicky; Nina Eikelis; Kazuko Masuo; Gavin Lambert; Elisabeth Lambert
Journal:  Hypertension       Date:  2006-09-25       Impact factor: 10.190

3.  Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded order.

Authors:  M Timio; P Verdecchia; S Venanzi; S Gentili; M Ronconi; B Francucci; M Montanari; E Bichisao
Journal:  Hypertension       Date:  1988-10       Impact factor: 10.190

4.  Pseudopheochromocytoma.

Authors:  O Kuchel
Journal:  Hypertension       Date:  1985 Jan-Feb       Impact factor: 10.190

5.  Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.

Authors:  William J Elliott; Peter M Meyer
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

6.  Introversion associated with large differences between screening blood pressure and home blood pressure measurement: The Ohasama study.

Authors:  Atsushi Hozawa; Takayoshi Ohkubo; Taku Obara; Hirohito Metoki; Masahiro Kikuya; Kei Asayama; Kazuhito Totsune; Junichiro Hashimoto; Haruhisa Hoshi; Yumiko Arai; Hiroshi Satoh; Toru Hosokawa; Yutaka Imai
Journal:  J Hypertens       Date:  2006-11       Impact factor: 4.844

7.  Association of panic disorder and panic attacks with hypertension.

Authors:  S J Davies; P Ghahramani; P R Jackson; T W Noble; P G Hardy; J Hippisley-Cox; W W Yeo; L E Ramsay
Journal:  Am J Med       Date:  1999-10       Impact factor: 4.965

8.  Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Patrick O Monahan; Bernd Löwe
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

9.  Prevalence of the white-coat effect at multiple visits before and during treatment.

Authors:  Willem J Verberk; Abraham A Kroon; Theo Thien; Jacques W M Lenders; Gert A van Montfrans; Andries J Smit; Peter W de Leeuw
Journal:  J Hypertens       Date:  2006-12       Impact factor: 4.844

10.  Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.

Authors:  A M Sharma; T Wagner; P Marsalek
Journal:  J Hum Hypertens       Date:  2004-09       Impact factor: 3.012
View more
  2 in total

1.  Nocebo responses to antihypertensive medications.

Authors:  Ralph H Stern
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-09       Impact factor: 3.738

2.  Cardiovascular health in patients with serious mental illnesses: we need to do more.

Authors:  Keith C Ferdinand
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-09       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.